Prognostic significance of blood coagulation tests in lung cancer

European Respiratory Journal

Volumn 17, Issue 4, 2001, Pages 667-673

  Ferrigno, D ^a   Buccheri, G ^a   Ricca, I ^a  

^a S CROCE E CARLE HOSPITAL   (Italy)

Author keywords

Blood coagulation; Lung cancer; Prethrombotic state; Prognosis

Indexed keywords

ANTIPLASMIN; ANTITHROMBIN III; BLOOD CLOTTING FACTOR 7; BLOOD CLOTTING FACTOR 9; D DIMER; FIBRINOGEN; PLASMINOGEN; PROTEIN C; PROTHROMBIN;

ADULT; AGED; ANTHROPOMETRY; ARTICLE; BLOOD CLOTTING; BLOOD CLOTTING TEST; CANCER SURVIVAL; CLINICAL EXAMINATION; CONTROLLED STUDY; EARLY CANCER; FEMALE; FOLLOW UP; HUMAN; LABORATORY TEST; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; PARTIAL THROMBOPLASTIN TIME; PHYSICAL EXAMINATION; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; PROTHROMBIN TIME; RADIOGRAPHY; STATISTICAL MODEL; THROMBOCYTE COUNT;

ADULT; AGED; AGED, 80 AND OVER; BLOOD COAGULATION; BLOOD COAGULATION FACTORS; BLOOD COAGULATION TESTS; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; PARTIAL THROMBOPLASTIN TIME; PLATELET COUNT; PROGNOSIS; PROSPECTIVE STUDIES; PROTHROMBIN TIME;

EID: 0034997583     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: 10.1183/09031936.01.17406670     Document Type: Article

References (30)

1. Phlegmasia alba dolens
2. Evaluating prethrombotic state in lung cancer using molecular markers
3. Haemostatic abnormalities in lung cancer: Prognostic implications
4. Coagulation abnormalities in malignancy: A review
5. Alterations to the fibrinolytic enzyme system in patients with non-small cell lung carcinoma
6. Effect of warfarin anticoagulation on survival in carcinoma of the lung, colon, head and neck, and prostate
7. Subcutaneous heparin treatment increases survival in small cell lung cancer
8. Clotting factors in tumor tissue: Implications for cancer therapy
9. Alteration of coagulation and fibrinolysis systems after multidrug anticancer therapy for lung cancer
10. Activation of coagulation and fibrinolysis in patients with lung cancer: Relation to tumour stage and prognosis
11. International histological classification of tumours
12. Revisions in the International system for staging lung cancer
13. Appraisal of methods for the study of chemotherapy in man: Comparative therapeutic trial of nitrogen mustard and triethylene thiophosphoramide
14. Is the MVP regimen less active than previously described? Results of a phase II study in advanced non-small cell lung cancer
15. Vinorelbine in elderly patients with inoperable non small cell lung carcinoma
16. Serum tumour markers in lung cancer: History, biology and clinical applications
17. Nonparametric statistics for the behavioural sciences
18. Non-parametric estimation from incomplete observations
19. Design and analysis of randomized clinical trials requiring prolonged observation of each patient: II Analysis and examples
20. Regression models and life tables
21. Prognostic factors in lung cancer: Tables and comments
22. The diagnosis of bleeding disorders
23. Laboratory diagnosis of the thrombofilic state in cancer patients
24. Prognostic significance of thrombocytosis in patients with primary lung cancer
25. Mechanism of fibrinolysis
26. Costantini Pathways of coagulation/fibrinolysis activation in malignancy
27. Pretreatment fibrinogen levels are associated with response to chemotherapy in patients with small cell carcinoma of the lung: Department of veterans affairs cooperative study 188
28. Prognostic significance of plasma D-dimer levels in patients with lung cancer
29. Prognostic significance of blood coagulation tests in carcinoma of the lung and colon
30. High plasma level of plasmin-alpha2-plasmin inhibitor complex is predictor of poor prognosis in patients with lung cancer